Funder: National Institutes of Health
Due Dates: April 4, 2025 (New/Renewal/Resubmission) | October 3, 2025 (New/Renewal/Resubmission) | Letter of Intent: 30 days prior to due date
Funding Amounts: Up to $150,000 direct costs per year, for up to 3 years; estimated 17 awards; modular budget expected (unless foreign org).
Summary: Supports early-stage, highly innovative technology development for molecular and cellular analysis in basic or clinical cancer research; clinical trials are not allowed.
Key Information: Applications must include quantitative performance measures; projects focused on applying existing technologies or clinical trials are not eligible.